Moreover, in vitro and in vivo studies have confirmed that expression of the S100A4 protein by neutrophils promotes the progression of gliomas, leading to a transition to a mesenchymal glioblastoma phenotype and an increased proliferation rate. The gene discussed is S100A4; the disease is central nervous system cancer.